Form D · Biotechnology
ABVC BIOPHARMA, INC.
Fremont, CA · CIK 0001173313
Offering snapshot reported Nov 10, 2026 · SEC filing
- Reported sold
- $3.39M Offering amount: $3.39M
- Investors reported
- 9 Form D · investor count
- Minimum accepted
- $125K Reported outside-investor minimum
- First sale
- Oct 30, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 10, 2026 | Initial | $3,387,500 | No comparison | 9 | SEC filing |
| May 28, 2024 | Initial | $750,000 | No comparison | 1 | SEC filing |
| Mar 2, 2023 | Initial | $3,175,000 | No comparison | 1 | SEC filing |
| Jul 27, 2018 | Initial | $550,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Debt
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $237K
- Finders' fees
- $0
- Form D file number
- 021-604310
The amounts reported reflect the aggregate purchase price of $3,387,500 paid for senior convertible promissory notes with an aggregate principal amount of $4,106,060, issued at a 17.5% original issue discount.
WallachBeth Capital, LLC acted as exclusive placement agent for the private placement. The Company paid the placement agent a cash fee equal to 7% of the gross proceeds and reimbursed the placement agent for accountable expenses of $65,000.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| WallachBeth Capital, LLC | 000147853 | · CRD 000147853 |
Source: Form D, filed Nov 10, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Francis Chen | Director |
| Yen Hsin Chou | Director |
| Leeds Chow | Director |
| Yu Min (Francis) Chung | Director |
| Howard Doong | Executive |
| Che Wei Hsu | Director |
| Tsang Shann Jiang | Director |
| Tsung Shann (T.S.) Jiang | Director |
| Tsang Ming Jiang | Director |
| Eugene Jiang | Director, Executive |
| Tsung Shann Jiang | Director, Executive |
| Chang Jen Jiang | Director |
| Shuling Jiang | Director |
| Hsin Hui Miao | Director |
| Yoshinobu Odaira | Director |
| Uttam Patil | Executive |
| Norimi Sakamoto | Director |
| Ming Fong Wu | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
44370 Old Warm Springs Blvd
Fremont, CA, 94538
Fremont, CA, 94538